Results 131 to 140 of about 25,303 (250)
PCSK9 inhibitors (Proprotein convertase subtilisin-kexin9 inhibitors) not only have a good lipid-lowering effect but also have the effects of improving cardiovascular outcome, anti-inflammation, reducing oxidative stress and improving vascular ...
She, Lin-Cong +7 more
core +1 more source
Repurposing an endogenous degradation domain for antibody-mediated disposal of cell-surface proteins
The exquisite specificity of antibodies can be harnessed to effect targeted degradation of membrane proteins. Here, we demonstrate targeted protein removal utilising a protein degradation domain derived from the endogenous human protein Proprotein ...
Janika Schmitt +6 more
doaj +1 more source
Effectiveness and Safety of Setmelanotide in a Patient With a Heterozygous PCSK1 Deficiency
ABSTRACT Setmelanotide, a melanocortin 4 receptor (MC4R) agonist, is a promising pharmacological treatment option for people with rare monogenic obesity conditions affecting the leptin‐melanocortin signaling pathway, including proprotein convertase subtilisin/kexin type 1 (PCSK1) gene mutations.
Ellina Lytvyak +2 more
wiley +1 more source
The characterisation of the ectodomain shedding of the low density lipoprotein receptor [PDF]
Includes abstract. Includes bibliographical references (leaves 142-155)
Parker, Ayesha
core
Regulation and Function of Proprotein Convertase PC5 in Rat Aortic Vascular Smooth Muscle Cells
PCs sind für die endoproteolytische Spaltung von zahlreichen Proproteinen, zu denen auch Integrine, EZM-Bestandteile und Peptidhormone gehören, während ihres Reifungsprozesses verantwortlich.
Kilimnik, Adam
core +1 more source
From Guidelines to Clinical Practice: Expert Perspectives on Long‐Term Management of Obesity
ABSTRACT An international panel of experts from the U.S. and China convened to discuss the 2026 TOS–OMA–OAC Expert Guidance Statement on the Pharmacological Management of Obesity, focusing on emerging evidence, regional considerations, and challenges in translating recommendations into long‐term care.
Hong Chen +5 more
wiley +1 more source
Background Alirocumab is a fully human monoclonal antibody to proprotein convertase subtilisin kexin type 9 used for the reduction of low-density lipoprotein cholesterol (LDL-C) in high-risk patients not reaching their LDL-C target.
Klaus G. Parhofer +6 more
doaj +1 more source
Obesity and hypertension co‐exist and share molecular mechanisms in terms of dietary therapy, modulated by food bioactive constituents. ABSTRACT Obesity and hypertension are among the most pressing global public health challenges. They frequently co‐exist, with obesity‐related hypertension accounting for an estimated 75% of the hypertension burden ...
Samuel Oluwasegun Maccarthy +3 more
wiley +1 more source
Proprotein convertase 5/6 (PC6) is a member of the proprotein convertase family that endoproteolytically cleave latent precursor proteins into their biologically active state.
G. Nie +5 more
core +1 more source
Extracellular matrix is the foundation upon which all tissues are built. The basement membrane of cells in one form of extracellular matrix that’s comprised of mainly type IV collagen. Peroxidasin (Pxdn), a matrix-bound protein, is the enzyme responsible
Colon, Selene Y
core +1 more source

